219121-22-9

Upstream product

• 110-89-4 piperidine 
• 219121-21-8 2-(2-benzyloxyethyl) malonic acid mono tert-butyl ester 

Downstream Products

• 219121-35-4 4-Hydroxy-2-{1-[(S)-2-(4-methoxy-phenyl)-1-methylcarbamoyl-ethylcarbamoyl]-cyclopentylmethyl}-butyric acid tert-butyl ester 
• 219121-25-2 4-Hydroxy-2-{1-[(S)-2-(4-methoxy-phenyl)-1-methylcarbamoyl-ethylcarbamoyl]-cyclohexylmethyl}-butyric acid tert-butyl ester 
• 219121-34-3 4-Benzyloxy-2-{1-[(S)-2-(4-methoxy-phenyl)-1-methylcarbamoyl-ethylcarbamoyl]-cyclopentylmethyl}-butyric acid tert-butyl ester 
• 219121-24-1 4-Benzyloxy-2-{1-[(S)-2-(4-methoxy-phenyl)-1-methylcarbamoyl-ethylcarbamoyl]-cyclohex-2-enylmethyl}-butyric acid tert-butyl ester 
• 219121-23-0 1-(4-benzyloxy-2-tert-butoxycarbonylbutyl)cyclohex-2-ene carboxylic acid 

Relevant academic research and scientific papers

CYCLIC IMIDE DERIVATIVES

The invention relates to a compound of the formula I STR1 wherein R 1 is a cyclic imide group and X, Y, R 2, and R 3 are as defined herein. The invention further relates to pharmaceutical compositions containing, and methods of using, compounds of the formula I. Compounds of the formula I are useful in the treatment of diseases related to the production of matrix metalloproteinases and tumor necrosis factor.